Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide vs Topiramate Monotherapy in Epilepsy: Cognitive Safety
2016-004955-64Phase 4
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in epilepsy comparing Zonisamide monotherapy with Topiramate monotherapy (2 arms). Primary endpoint: Percentage of Participants Who Were Seizure Free or Experienced Seizure Reduction at 24 Weeks.
02
Drugs
zonisamidetopiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2016-004955-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004955-64.